Brief: Humacyte Q3 Operating Expenses USD 30.233 Million
08/11/2024 13:00
Nov 08 (Reuters) - Humacyte Q3 operating income USD -30.233 million vs. IBES estimate USD -29.7 million. * Q3 net income USD -39.202 million vs. IBES estimate USD -30 million * Q3 basic EPS USD -0.33
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary